tiprankstipranks
Trending News
More News >
Pelthos Therapeutics (PTHS)
:PTHS
US Market

Pelthos Therapeutics (PTHS) Financial Statements

Compare
67 Followers

Pelthos Therapeutics Financial Overview

Pelthos Therapeutics's market cap is currently $77.48M. The company's EPS TTM is $; its P/E ratio is -1.41; Pelthos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 199.93K
Gross Profit$ 0.00$ 0.00$ 0.00$ -209.05K$ 61.35K
Operating Income$ -7.57M$ -6.86M$ -2.32M$ -839.00K$ -1.35M
EBITDA$ -7.17M$ -6.86M$ -2.32M$ 0.00$ 0.00
Net Income$ -7.96M$ -7.38M$ -2.46M$ -595.39K$ -660.58K
Balance Sheet
Cash & Short-Term Investments$ 513.44K$ 96.39K$ 55.07K$ 0.00$ 0.00
Total Assets$ 1.37M$ 96.39K$ 55.07K$ 0.00$ 71.87K
Total Debt$ 2.19M$ 1.27M$ 540.43K$ 1.10M$ 241.79K
Net Debt$ 1.67M$ 1.17M$ 485.36K$ 1.10M$ 241.79K
Total Liabilities$ 4.08M$ 6.54M$ 3.76M$ 3.68M$ 3.65M
Stockholders' Equity$ -2.71M$ -6.44M$ -3.71M$ -3.68M$ -3.58M
Cash Flow
Free Cash Flow$ -5.79M$ -981.03K$ -1.57M$ -1.59M$ -3.63M
Operating Cash Flow$ -5.79M$ -981.03K$ -1.57M$ -1.59M$ -3.63M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 6.21M$ 1.02M$ 1.62M$ 1.59M$ 3.63M
Currency in USD

Pelthos Therapeutics Earnings and Revenue History

Pelthos Therapeutics Debt to Assets

Pelthos Therapeutics Cash Flow

Pelthos Therapeutics Forecast EPS vs Actual EPS